Latest Articles

Publication Date
Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer - OncLive

Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer OncLive

Published: Nov. 7, 2024, 8:04 p.m.
Cancer genetic risk assessment guidelines expand to meet growing understanding of hereditary risk - EurekAlert

Cancer genetic risk assessment guidelines expand to meet growing understanding of hereditary risk EurekAlert

Published: Nov. 7, 2024, 3:18 p.m.
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk - Kilgore News Herald

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk Kilgore News Herald

Published: Nov. 7, 2024, 1:34 p.m.
B-Cell Protein Has Both Risk and Protective Factors in Endometrial Cancer - DocWire News

B-Cell Protein Has Both Risk and Protective Factors in Endometrial Cancer DocWire News

Published: Nov. 6, 2024, 7:14 p.m.
Artificial intelligence-assisted magnetic resonance imaging technology in the differential diagnosis and prognosis prediction of endometrial cancer - Nature.com

Artificial intelligence-assisted magnetic resonance imaging technology in the differential diagnosis and prognosis prediction of endometrial cancer Nature.com

Published: Nov. 6, 2024, 5:27 a.m.
Endometrial cancer survivor urges women to be their own health advocate - KEYE TV CBS Austin

Endometrial cancer survivor urges women to be their own health advocate KEYE TV CBS Austin

Published: Nov. 5, 2024, 4:42 p.m.
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens - OncLive

Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens OncLive

Published: Nov. 5, 2024, 3:07 p.m.
New Trends of Endometrial Cancer Market To Receive Overwhelming - openPR

New Trends of Endometrial Cancer Market To Receive Overwhelming openPR

Published: Nov. 5, 2024, 2:36 p.m.
Nouscom's Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to 'Intercept' Cancer - The Manila Times

Nouscom's Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to 'Intercept' Cancer The Manila Times

Published: Nov. 5, 2024, 2:11 p.m.
Role of HOXA10 in pathologies of the endometrium.

HOXA10 belongs to the homeobox gene family and is essential for uterine biogenesis, endometrial receptivity, embryo implantation, and stromal cell decidualization. Available evidence suggests that the expression of HOXA10 is …

Published: Nov. 5, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!